DBD Stock Summary and Trading Ideas (Diebold Nixdorf | NYSE:DBD)

Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.

Diebold Nixdorf trades on the NYSE stock market under the symbol DBD.

As of December 15, 2025, DBD stock price declined to $67.47 with 31,691 million shares trading.

DBD has a beta of 1.44, meaning it tends to be more sensitive to market movements. DBD has a correlation of 0.55 to the broad based SPY ETF.

DBD has a market cap of $2.42 billion. This is considered a Mid Cap stock.

Last quarter Diebold Nixdorf reported $945 million in Revenue and $1.39 earnings per share. This beat revenue expectation by $11 million and exceeded earnings estimates by $.57.

The top ETF exchange traded funds that DBD belongs to (by Net Assets): IWM, VTI, AVUV, VXF, VGT.

DBD has outperformed the market in the last year with a price return of +41.2% while the SPY ETF gained +14.0%. DBD has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +13.9% and +4.6%, respectively, while the SPY returned +3.9% and -0.3%, respectively.

DBD support price is $65.95 and resistance is $69.41 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DBD shares will trade within this expected range on the day.